Literature DB >> 23936604

The contribution of melanocytes to pathological scar formation during wound healing.

Fu-Lei Gao1, Rong Jin, Lu Zhang, Yu-Guang Zhang.   

Abstract

Both hypertrophic scars and keloid scars are caused by abnormal wound healing, the key feature of which is excess collagen fiber secretion by fibroblasts. Many different factors could affect the process of hypertrophic scar and keloid formation, but most have not been identified to date. We assume that, during wound healing, melanocytes from the stratum basale contact or interact with fibroblasts from the dermal layers after the basal membrane is damaged, which in turn facilitates fibroblast proliferation and the secretion and deposition of collagen. This plays a significant role in the generation of hypertrophic scars and keloids.

Entities:  

Keywords:  Melanocyte; fibroblast; keloid; scar; wound healing

Year:  2013        PMID: 23936604      PMCID: PMC3731197     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  9 in total

1.  PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.

Authors:  Xia Lin; Xueyan Duan; Yao-Yun Liang; Ying Su; Katharine H Wrighton; Jianyin Long; Min Hu; Candi M Davis; Jinrong Wang; F Charles Brunicardi; Yigong Shi; Ye-Guang Chen; Anming Meng; Xin-Hua Feng
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

Review 2.  Hypertrophic scars and keloids. A collective review.

Authors:  L D Ketchum; I K Cohen; F W Masters
Journal:  Plast Reconstr Surg       Date:  1974-02       Impact factor: 4.730

3.  Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.

Authors:  Zhan-Feng Zhang; Yan-Gang Zhang; Da-Hai Hu; Ji-Hong Shi; Jia-Qi Liu; Zhou-Ting Zhao; Hong-Tao Wang; Xiao-Zhi Bai; Wei-Xia Cai; Hua-Yu Zhu; Chao-Wu Tang
Journal:  Burns       Date:  2011-01-14       Impact factor: 2.744

4.  In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation.

Authors:  Muriel Cario-André; Catherine Pain; Yvon Gauthier; Vincent Casoli; Alain Taieb
Journal:  Pigment Cell Res       Date:  2006-10

5.  Neuropeptide regulation of immunity. The immunosuppressive activity of alpha-melanocyte-stimulating hormone (alpha-MSH).

Authors:  A W Taylor; D G Yee; T Nishida; K Namba
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

6.  Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.

Authors:  G S Chin; W Liu; Z Peled; T Y Lee; D S Steinbrech; M Hsu; M T Longaker
Journal:  Plast Reconstr Surg       Date:  2001-08       Impact factor: 4.730

7.  Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells.

Authors:  R Wang; A Ghahary; Q Shen; P G Scott; K Roy; E E Tredget
Journal:  Wound Repair Regen       Date:  2000 Mar-Apr       Impact factor: 3.617

8.  A combined candidate therapy for the scar-free repair of cleft lip based on inhibitors of TGF-β.

Authors:  Qian Zhu; Jian Li
Journal:  Med Hypotheses       Date:  2010-09-09       Impact factor: 1.538

9.  Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts.

Authors:  Zhi Zhang; Tania M Garron; Xiao-Jian Li; Yan Liu; Xiong Zhang; Ye-Yang Li; Wei-Shi Xu
Journal:  Burns       Date:  2009-01-23       Impact factor: 2.744

  9 in total
  12 in total

1.  Risk factors of keloids in Syrians.

Authors:  Abeer Shaheen; Jamal Khaddam; Fadi Kesh
Journal:  BMC Dermatol       Date:  2016-09-20

2.  Exosomes released by melanocytes modulate fibroblasts to promote keloid formation: a pilot study.

Authors:  Zeren Shen; Jinjin Shao; Jiaqi Sun; Jinghong Xu
Journal:  J Zhejiang Univ Sci B       Date:  2022-08-15       Impact factor: 5.552

3.  "Never Trust the Skin": A Rationale for Using Polydioxanone Internal Support Matrix to Minimize Scarring in Primary Mastopexy-Augmentation-An Observational Study.

Authors:  Julia A Chiemi; Shahrooz Sean Kelishadi
Journal:  Aesthet Surg J Open Forum       Date:  2022-05-19

4.  A multimodal assessment of melanin and melanocyte activity in abnormally pigmented hypertrophic scar.

Authors:  Taryn E Travis; Pejhman Ghassemi; Jessica C Ramella-Roman; Nicholas J Prindeze; Dereck W Paul; Lauren T Moffatt; Marion H Jordan; Jeffrey W Shupp
Journal:  J Burn Care Res       Date:  2015 Jan-Feb       Impact factor: 1.845

Review 5.  Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.

Authors:  Jonathan P Andrews; Jaana Marttala; Edward Macarak; Joel Rosenbloom; Jouni Uitto
Journal:  Matrix Biol       Date:  2016-02-02       Impact factor: 11.583

Review 6.  Understanding Scarring in the Oral Mucosa.

Authors:  Michelle F Griffin; Evan J Fahy; Megan King; Nicholas Guardino; Kellen Chen; Darren B Abbas; Christopher V Lavin; Nestor M Diaz Deleon; H Peter Lorenz; Michael T Longaker; Derrick C Wan
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-10-12       Impact factor: 4.947

7.  Melanocytes from Patients Affected by Ullrich Congenital Muscular Dystrophy and Bethlem Myopathy have Dysfunctional Mitochondria That Can be Rescued with Cyclophilin Inhibitors.

Authors:  Alessandra Zulian; Francesca Tagliavini; Erika Rizzo; Camilla Pellegrini; Francesca Sardone; Nicoletta Zini; Nadir Mario Maraldi; Spartaco Santi; Cesare Faldini; Luciano Merlini; Valeria Petronilli; Paolo Bernardi; Patrizia Sabatelli
Journal:  Front Aging Neurosci       Date:  2014-11-20       Impact factor: 5.750

Review 8.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

9.  Keloid pathophysiology: fibroblast or inflammatory disorders?

Authors:  Ferdinand W Nangole; George W Agak
Journal:  JPRAS Open       Date:  2019-11-05

10.  Transcriptional Differences of Coding and Non-Coding Genes Related to the Absence of Melanocyte in Skins of Bama Pig.

Authors:  Long Jin; Lirui Zhao; Silu Hu; Keren Long; Pengliang Liu; Rui Liu; Xuan Zhou; Yixin Wang; Zhiqing Huang; Xuxu Lin; Qianzi Tang; Mingzhou Li
Journal:  Genes (Basel)       Date:  2019-12-30       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.